{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:40:49Z","timestamp":1767141649598,"version":"build-2238731810"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1F32HL156614-01"],"award-info":[{"award-number":["1F32HL156614-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL155955-01A1"],"award-info":[{"award-number":["1R01HL155955-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1UG3 HL143192-01A1"],"award-info":[{"award-number":["1UG3 HL143192-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parker B. Francis Fellowship"},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["FTF17FTF33670369"],"award-info":[{"award-number":["FTF17FTF33670369"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["CCCR P30 AR072571"],"award-info":[{"award-number":["CCCR P30 AR072571"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["2UL1TR001430-05A1"],"award-info":[{"award-number":["2UL1TR001430-05A1"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["U1EMC27864\u201008\u201000"],"award-info":[{"award-number":["U1EMC27864\u201008\u201000"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Forma Therapeutics"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10557-022-07420-1","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T01:05:01Z","timestamp":1672967101000},"page":"651-656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-3766","authenticated-orcid":false,"given":"Justin K.","family":"Lui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchika A.","family":"Sangani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari R.","family":"Gillmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Vakhshoorzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin A.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea M.","family":"Bujor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa M.","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renda Soylemez","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"LaValley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth S.","family":"Klings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"issue":"1","key":"7420_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11926-012-0302-2","volume":"15","author":"A Yaqub","year":"2013","unstructured":"Yaqub A, Chung L. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. Curr Rheumatol Rep. 2013;15(1):302.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"7420_CR2","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.","journal-title":"Eur Respir J"},{"issue":"4","key":"7420_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903\u201375.","journal-title":"Eur Respir J"},{"issue":"138","key":"7420_CR4","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1183\/16000617.0062-2015","volume":"24","author":"S Rosenkranz","year":"2015","unstructured":"Rosenkranz S, Preston IR. Right heart catheterisation: best practice and pitfalls in pulmonary hypertension. Eur Respir Rev. 2015;24(138):642\u201352.","journal-title":"Eur Respir Rev"},{"issue":"9","key":"7420_CR5","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/art.22069","volume":"54","author":"MR Fisher","year":"2006","unstructured":"Fisher MR, Mathai SC, Champion HC, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum. 2006;54(9):3043\u201350.","journal-title":"Arthritis Rheum"},{"issue":"145","key":"7420_CR6","doi-asserted-by":"publisher","first-page":"170056","DOI":"10.1183\/16000617.0056-2017","volume":"26","author":"D Launay","year":"2017","unstructured":"Launay D, Sobanski V, Hachulla E, Humbert M. Pulmonary hypertension in systemic sclerosis: different phenotypes. Eur Respir Rev. 2017;26(145):170056.","journal-title":"Eur Respir Rev"},{"issue":"4","key":"7420_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1183\/09031936.00091212","volume":"42","author":"BD Fox","year":"2013","unstructured":"Fox BD, Shimony A, Langlebon D, et al. High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J. 2013;42(4):1083\u201391.","journal-title":"Eur Respir J"},{"issue":"7","key":"7420_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/acr.24724","volume":"74","author":"JK Lui","year":"2022","unstructured":"Lui JK, Sangani RA, Chen CA, et al. Prognostic value of cardiac axis deviation in systemic sclerosis-related pulmonary hypertension. Arthritis Care Res (Hoboken). 2022;74(7):1219\u201326.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"Suppl 4","key":"7420_CR9","doi-asserted-by":"publisher","first-page":"iv14","DOI":"10.1093\/rheumatology\/kel312","volume":"45","author":"A Kahan","year":"2006","unstructured":"Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatol (Oxford). 2006;45(Suppl 4):iv14.","journal-title":"Rheumatol (Oxford)"},{"issue":"4","key":"7420_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.rmed.2009.11.015","volume":"104","author":"AR Tonelli","year":"2010","unstructured":"Tonelli AR, Alnuaimat H, Mubarak K. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respir Med. 2010;104(4):481\u201396.","journal-title":"Respir Med"},{"issue":"2","key":"7420_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1378\/chest.11-0676","volume":"141","author":"RL Benza","year":"2012","unstructured":"Benza RL, Gomberg-Maitland M, Miller DP, et al. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest. 2012;141(2):354\u201362.","journal-title":"Chest"},{"issue":"2","key":"7420_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","volume":"156","author":"RL Benza","year":"2019","unstructured":"Benza RL, Gomberg-Maitland M, Elliott CG, et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies. Chest. 2019;156(2):323\u201337.","journal-title":"Chest"},{"issue":"1","key":"7420_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.chest.2020.08.2069","volume":"159","author":"RL Benza","year":"2021","unstructured":"Benza RL, Kanwar MK, Raina A, et al. Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension. Chest. 2021;159(1):337\u201346.","journal-title":"Chest"}],"updated-by":[{"DOI":"10.1007\/s10557-023-07431-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000}}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-022-07420-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-022-07420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T02:23:40Z","timestamp":1715912620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-022-07420-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["7420"],"URL":"https:\/\/doi.org\/10.1007\/s10557-022-07420-1","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"26 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10557-023-07431-6","URL":"https:\/\/doi.org\/10.1007\/s10557-023-07431-6","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was retrospective, single-center, observational study of patients with systemic sclerosis enrolled into the Scleroderma Biorepository at Boston University Chobanian & Avedisian School of Medicine. At the time of enrollment, patients were consented for inclusion in this longitudinal clinical registry. The study was approved by the Boston University Medical Campus and Boston Medical Center Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors affirm that the study participants provided informed consent for publication of results in a medical book or journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"J. K. L. received research support from United Therapeutics. E. S. K. received royalties for 3 topic cards in UpToDate. She is a consultant\/advisory board member for Bluebird Bio, FORMA Therapeutics, Vertex, and CSL Behring for sickle cell disease-related clinical trials (no conflict with the present work). All other authors declare no financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The views presented here do not necessarily reflect the views of the Department of Veterans Affairs or the US government.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}